Ftse Mib
34.736,49
0,71%
DAX
18.642,88
0,86%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
69.016,02
1,87%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Seneca Biopharma Inc (SNCA) Seneca Biopharma Inc (SNCA) Notizie

SNCA

Seneca Biopharma (SNCA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNCA
DataOraFonteTitoloSimboloCompagnia
15/06/202300:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNCASeneca Biopharma Inc
09/06/202315:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNCASeneca Biopharma Inc
28/04/202312:17Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNCASeneca Biopharma Inc
27/04/202312:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:SNCASeneca Biopharma Inc
21/04/202322:52Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SNCASeneca Biopharma Inc
21/04/202321:41Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SNCASeneca Biopharma Inc
21/04/202321:37Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNCASeneca Biopharma Inc
21/04/202321:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNCASeneca Biopharma Inc
22/03/202322:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNCASeneca Biopharma Inc
15/02/202322:41Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNCASeneca Biopharma Inc
13/02/202322:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNCASeneca Biopharma Inc
19/01/202312:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SNCASeneca Biopharma Inc
04/01/202317:00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNCASeneca Biopharma Inc
14/11/202214:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNCASeneca Biopharma Inc
22/08/202223:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SNCASeneca Biopharma Inc
22/08/202223:22Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:SNCASeneca Biopharma Inc
22/08/202212:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNCASeneca Biopharma Inc
12/08/202222:19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SNCASeneca Biopharma Inc
29/07/202223:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNCASeneca Biopharma Inc
18/03/202221:49Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SNCASeneca Biopharma Inc
18/03/202221:46Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNCASeneca Biopharma Inc
14/09/202114:01Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:SNCASeneca Biopharma Inc
16/08/202114:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:SNCASeneca Biopharma Inc
13/07/202122:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SNCASeneca Biopharma Inc
26/04/202113:00PR Newswire (US)Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.NASDAQ:SNCASeneca Biopharma Inc
20/04/202113:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNCASeneca Biopharma Inc
19/04/202113:00GlobeNewswire Inc.Leading BioSciences Provides Update to Seneca Biopharma, Inc. Stockholders on Merger Closing Process Following Virtual Specia...NASDAQ:SNCASeneca Biopharma Inc
13/04/202105:15GlobeNewswire Inc.Leading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to Vote at the Virtual Special Mee...NASDAQ:SNCASeneca Biopharma Inc
12/04/202113:00PR Newswire (US)Seneca Biopharma, Inc. Announces (i) Voting Results from the Special Meeting of Stockholders and (ii) New Special Meeting Dat...NASDAQ:SNCASeneca Biopharma Inc
02/04/202117:35GlobeNewswire Inc.Leading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of Proposed Merger with Seneca Biopharma...NASDAQ:SNCASeneca Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNCA

La tua Cronologia

BOV
FCXO34M
Freeport McMoRan
COIN
FRTCEUR
EU
BE0002655364
SD Worx Holding 3.8% 11j...
USOTC
TROYF
Troy Minerals (QB)
TG
NGS
Natural Gas Servic Dl 01
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network